Effectiveness Of Melatonin In Preventing Delirium In Critically Ill Patients
- Conditions
- Health Condition 1: F05- Delirium due to known physiological condition
- Registration Number
- CTRI/2021/06/034425
- Lead Sponsor
- Dr Priyamvada Gupta
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Critically ill patients Age >18 or < 70
2. Within the first 24 h of admission in the ICU
3.Anticipated ICU stay 5 days or more
4.No basic delirium or mood changes before admission in ICU
If they had less than 5 days of ICU stay
2. Sensitivity reaction to the melatonin supplement.
3. Pregnancy
4. Previous history of seizure or active seizure
5. ICU admission more than 24 hours at the time of screening
6. Unable to assess for delirium
7. History of severe cognitive or neurodegenerative disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method